Literature DB >> 154982

Suppression of lymphoproliferative responses to alloantigens by autologous AML cells.

G M Taylor, W D Fergusson, R Harris.   

Abstract

Autologous acute myeloid leukaemia (AML), cells caused the suppression of incorporation of 3H-thymidine (3H-Tdr) by remission lymphocytes stimulated with allogeneic cells. In five patients, autologous AML cells suppressed 3H-Tdr uptake by lymphocytes stimulated with up to three different allogeneic cells. Responses to allogeneic AML cells were more strongly suppressed than responses to pooled allogeneic lymphocytes. Suppression was abolished by ultrasonic disintegration of the autologous AML cells, suggesting that a soluble factor was not involved. Suppression was absent from autologous AML cells exposed to ultraviolet light, or when untreated autologous AML cells were present in ratios of less than 1:1 to lymphocytes, or when added 24 or more hours after stimulation of remission lymphocytes with allogeneic cells. It is suggested that suppression is a property of the differentiative level of AML cells, rather than of their malignant properties, although malignant-transformation may bring AML cells into contact with circulating T cells in vivo. Autologous AML cells seem to interfere with the recognition phase of T cell function.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 154982      PMCID: PMC1537600     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  In vitro generation of suppressor cell activity: suppression of in vitro induction if cell-mediated cytotoxicity.

Authors:  R J Hodes; K S Hathcock
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

2.  Mechanism of mastocytoma-mediated suppression of lymphocyte reactivity.

Authors:  F DeLustro; B F Argyris
Journal:  J Immunol       Date:  1976-12       Impact factor: 5.422

3.  In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats.

Authors:  M Glaser; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

4.  Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.

Authors:  H Kirchner; A V Muchmore; T M Chused; H T Holden; R B Herberman
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

5.  Suppressor cells in tumor-bearing mice capable of nonspecific blocking of in vitro immunization against transplant antigens.

Authors:  A E Eggers; J R Wunderlich
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

6.  Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors.

Authors:  M Glaser; H Kirchner; R B Herberman
Journal:  Int J Cancer       Date:  1975-09-15       Impact factor: 7.396

7.  Stimulation of human lymphocytes in vitro by leucocytes from patients with untreated acute myeloid leukaemia.

Authors:  G M Taylor; S V Jones; J C Ridway; R Harris
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

8.  Generation of cytotoxic cells in absence of blastogenesis by mouse leukemic cells in mixed cultures.

Authors:  D Collavo; G Biasi; A Colombatti; L Chieco-Bianchi
Journal:  Eur J Immunol       Date:  1976-09       Impact factor: 5.532

9.  Cell-mediated cytotoxicity as a result of immunotherapy in patients with acute myeloid leukaemia.

Authors:  G M Taylor; R Harris; C B Freeman
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

10.  Response of remission lymphocytes to autochthonous leukaemic myeloblasts.

Authors:  G M Taylor; C B Freeman; R Harris
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

View more
  3 in total

1.  An HLA-DR negative acute leukaemia which stimulates MLC and CMC responses.

Authors:  G M Taylor; W Fergusson; P A Dyer; R Harris; G Morrell
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 2.  Gene-modified dendritic cells for immunotherapy against cancer.

Authors:  Andreas Lundqvist; Pavel Pisa
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

3.  Lack of correlation between lymphocyte activating determinants and HLA-DR on acute leukaemias.

Authors:  G M Taylor; J C Ridway; W D Fergusson; R Harris
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.